Neumora Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - NMRA
Portfolio Pulse from
A securities fraud class action lawsuit is pending against Neumora Therapeutics, Inc. (NASDAQ:NMRA). Investors who suffered losses are encouraged to contact Levi & Korsinsky before April 7, 2025, to discuss potential recovery under federal securities laws.
March 18, 2025 | 11:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Neumora Therapeutics is facing a securities fraud class action lawsuit. Investors are advised to contact Levi & Korsinsky by April 7, 2025, for potential recovery.
The pending securities fraud class action lawsuit against Neumora Therapeutics is likely to negatively impact its stock price in the short term due to potential legal liabilities and investor concerns.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100